| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2004 | CA2487356A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 01/08/2004 | CA2482161A1 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/08/2004 | CA2481890A1 Synergistic interaction of abacavir and alovudine |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378516A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for HIV |
| 01/07/2004 | EP1378512A1 Optically pure camptothecin analogues |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1378508A1 Various forms of paroxetine hydrochloride anhydrate |
| 01/07/2004 | EP1378507A2 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 01/07/2004 | EP1378267A1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1378238A1 Pharmaceutical compositions containing donepezil hydrochloride |
| 01/07/2004 | EP1378237A1 Remedial agent for chronic articular rheumatism |
| 01/07/2004 | EP1378236A1 Agents against stress-induced diseases drugs |
| 01/07/2004 | EP1378235A1 Metoprolol for the treatment of schizophrenia related diseases |
| 01/07/2004 | EP1378234A1 Effervescent bisphosphonate formulation |
| 01/07/2004 | EP1378224A1 Sugar intake promoters |
| 01/07/2004 | EP1378177A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377678A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377673A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377591A1 Tumour inhibiting gallium compounds |
| 01/07/2004 | EP1377590A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377588A1 4-beta-1''-[(2''-(substituted benzoyl)anilino] podophyllotoxin analogues useful as anticancer agents |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377585A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377584A1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377582A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377581A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 01/07/2004 | EP1377577A1 Pyrrole derivates for treating cytokine mediated diseases |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377575A1 Antiviral pyrazolopyridine compounds |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | EP1377570A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377565A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377554A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 01/07/2004 | EP1377553A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 01/07/2004 | EP1377552A1 Metal complexes and therapeutic uses thereof |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377545A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377353A1 Cell separation compositions and methods |
| 01/07/2004 | EP1377344A2 Medicine for treating female sexual dysfunction by acting on the central nervous system |
| 01/07/2004 | EP1377339A2 Method for preventing acute renal failure |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | EP1377316A1 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/07/2004 | EP1377315A2 Pharmaceutical compositions |
| 01/07/2004 | EP1377311A2 Treatment of neuropathologies associated with expression of tnf-alpha |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377309A1 Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377300A1 Zinc ionophores as anti-stress agents |
| 01/07/2004 | EP1377298A2 Combined method for treating hormono-dependent disorders |
| 01/07/2004 | EP1377297A2 Degradation-resistant glucocorticosteroid formulations |
| 01/07/2004 | EP1377296A2 Antiviral method of use |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377294A2 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 01/07/2004 | EP1377293A1 Aryl and biaryl piperidines used as mch antagonists |
| 01/07/2004 | EP1377292A2 Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377289A2 Heterocyclic compounds for therapeutic use |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377287A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 01/07/2004 | EP1377286A1 Treatment of schizophrenia |
| 01/07/2004 | EP1377285A1 Pharmaceutical composition comprising ibuprofen and prochlorperazine |
| 01/07/2004 | EP1377284A1 Controlled release arginine formulations |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377281A1 Taurine compounds |
| 01/07/2004 | EP1377280A2 Bulking agents as satiety agents |
| 01/07/2004 | EP1377279A2 Inhibition of erk to reduce or prevent tolerance to and dependence on opioid analgesics |
| 01/07/2004 | EP1377278A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv |
| 01/07/2004 | EP1377277A1 Pharmaceutical compositions comprising pravastatin for reducing ldl cholesterol levels |